The effect of serum triglyceride levels and different lipid-lowering methods on the prognosis of hypertriglyceridemic acute pancreatitis: a single-center 12-year retrospective study by propensity score matching

References

• Gukovskaya AS, Gorelick FS, Groblewski GE, et al. Recent insights into the pathogenic mechanism of pancreatitis: role of acinar cell organelle disorders. Pancreas. 2019;48(4):459–470. doi: 10.1097/MPA.0000000000001298.
   PubMed Web of Science ®Google Scholar
• Jin M, Bai X, Chen X, et al. A 16-year trend of etiology in acute pancreatitis: the increasing proportion of hypertriglyceridemia-associated acute pancreatitis and its adverse effect on prognosis. J Clin Lipidol. 2019;13(6):947–953.e1. doi: 10.1016/j.jacl.2019.09.005.
   PubMed Web of Science ®Google Scholar
• Pu W, Luo G, Chen T, et al. A 5-year retrospective cohort study: epidemiology, etiology, severity, and outcomes of acute pancreatitis. Pancreas. 2020;49(9):1161–1167. doi: 10.1097/MPA.0000000000001637.
   PubMed Web of Science ®Google Scholar
• Olesen SS, Harakow A, Krogh K, et al. Hypertriglyceridemia is often under recognized as an aetiologic risk factor for acute pancreatitis: a population-based cohort study. Pancreatology. 2021;21(2):334–341. doi: 10.1016/j.pan.2021.02.005.
   PubMed Web of Science ®Google Scholar
• Valdivielso P, Ramírez-Bueno A, Ewald N. Current knowledge of hypertriglyceridemic pancreatitis. Eur J Intern Med. 2014;25(8):689–694. doi: 10.1016/j.ejim.2014.08.008.
   PubMed Web of Science ®Google Scholar
• Pothoulakis I, Paragomi P, Tuft M, et al. Association of serum triglyceride levels with severity in acute pancreatitis: results from an international, multicenter cohort study. Digestion. 2021;102(5):809–813. doi: 10.1159/000512682.
   PubMed Web of Science ®Google Scholar
• Kiss L, Fűr G, Mátrai P, et al. The effect of serum triglyceride concentration on the outcome of acute pancreatitis: systematic review and meta-analysis. Sci Rep. 2018;8(1):14096. doi: 10.1038/s41598-018-32337-x.
   PubMedGoogle Scholar
• Christian JB, Arondekar B, Buysman EK, et al. Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg/dL in patients with severe hypertriglyceridemia. J Clin Lipidol. 2012;6(5):450–461. doi: 10.1016/j.jacl.2012.08.007.
   PubMed Web of Science ®Google Scholar
• Chinese pancreatic surgery association, chinese society of surgery, chinese medical association; [Guidelines for diagnosis and treatment of acute pancreatitis in China (2021)]. Zhonghua Wai ke za Zhi [Chin J Surg]. 2021;59(7):578–587. doi: 10.3760/cma.j.cn112139-20210416-00172.
   PubMedGoogle Scholar
• Dhindsa S, Sharma A, Al-Khazaali A, et al. Intravenous insulin versus conservative management in hypertriglyceridemia-associated acute pancreatitis. J Endocr Soc. 2019;4(1):bvz019. doi: 10.1210/jendso/bvz019.
   PubMed Web of Science ®Google Scholar
• Banks PA, Bollen TL, Dervenis C, et al. Acute pancreatitis classification working group. Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–111. doi: 10.1136/gutjnl-2012-302779.
   PubMed Web of Science ®Google Scholar
• Lin XY, Zeng Y, Zhang ZC, et al. Incidence and clinical characteristics of hypertriglyceridemic acute pancreatitis: a retrospective single-center study. WJG. 2022;28(29):3946–3959. doi: 10.3748/wjg.v28.i29.3946.
   PubMed Web of Science ®Google Scholar
• Mosztbacher D, Hanák L, Farkas N, et al. Hungarian pancreatic study group. Hypertriglyceridemia-induced acute pancreatitis: a prospective, multicenter, international cohort analysis of 716 acute pancreatitis cases. Pancreatology. 2020;20(4):608–616. doi: 10.1016/j.pan.2020.03.018.
   PubMed Web of Science ®Google Scholar
• Li X, Ke L, Dong J, et al. Significantly different clinical features between hypertriglyceridemia and biliary acute pancreatitis: a retrospective study of 730 patients from a tertiary center. BMC Gastroenterol. 2018;18(1):89. doi: 10.1186/s12876-018-0821-z.
   PubMedGoogle Scholar
• Maléth J, Balázs A, Pallagi P, et al. Alcohol disrupts levels and function of the cystic fibrosis transmembrane conductance regulator to promote development of pancreatitis. Gastroenterology. 2015;148(2):427–439.e16. doi: 10.1053/j.gastro.2014.11.002.
   PubMed Web of Science ®Google Scholar
• Hegyi P, Petersen OH. The exocrine pancreas: the acinar-ductal tango in physiology and pathophysiology. Rev Physiol Biochem Pharmacol. 2013;165:1–30. doi: 10.1007/112_2013_14.
   PubMed Web of Science ®Google Scholar
• Navina S, Acharya C, DeLany JP, et al. Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity. Sci Transl Med. 2011;3(107):107ra110. doi: 10.1126/scitranslmed.3002573.
   PubMed Web of Science ®Google Scholar
• Cook JR, Hawkins MA, Pajvani UB. Liver insulinization as a driver of triglyceride dysmetabolism. Nat Metab. 2023;5(7):1101–1110. doi: 10.1038/s42255-023-00843-6.
   PubMedGoogle Scholar
• Zheng D, Dou J, Liu G, et al. Association between triglyceride level and glycemic control among insulin-treated patients with type 2 diabetes. J Clin Endocrinol Metab. 2019;104(4):1211–1220. doi: 10.1210/jc.2018-01656.
   PubMed Web of Science ®Google Scholar
• Ghodsian N, Abner E, Emdin CA, et al. Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease. Cell Rep Med. 2021;2(11):100437. doi: 10.1016/j.xcrm.2021.100437.
   PubMedGoogle Scholar
• Ding L, Li S, Cao L, et al. Recurrence of hypertriglyceridemia-associated acute pancreatitis: a multicenter, prospective cohort study. Eur J Intern Med. 2024;S0953-6205(24):00130–00134. doi: 10.1016/j.ejim.2024.03.022.
   Google Scholar
• He W, Cai W, Yang X, et al. Insulin or blood purification treatment for hypertriglyceridaemia-associated acute pancreatitis: a systematic review and meta-analysis. Pancreatology. 2022;22(7):846–857. doi: 10.1016/j.pan.2022.07.013.
   PubMed Web of Science ®Google Scholar
• Padmanabhan A, Connelly-Smith L, Aqui N, et al. Guidelines on the use of therapeutic apheresis in clinical practice – evidence-based approach from the writing committee of the American society for apheresis: the eighth special issue. J Clin Apher. 2019;34(3):171–354. doi: 10.1002/jca.21705.
   PubMed Web of Science ®Google Scholar
• Gubensek J. The role of apheresis and insulin therapy in hypertriglyceridemic acute pancreatitis-a concise review. BMC Gastroenterol. 2023;23(1):341. doi: 10.1186/s12876-023-02957-3.
   PubMed Web of Science ®Google Scholar
• Cao L, Chen Y, Liu S, Chinese Acute Pancreatitis Clinical Trials Group (CAPCTG)., et al. Early plasmapheresis among patients with hypertriglyceridemia-associated acute pancreatitis. JAMA Netw Open. 2023;6(6):e2320802. doi: 10.1001/jamanetworkopen.2023.20802.
   PubMed Web of Science ®Google Scholar
• Kuchay MS, Farooqui KJ, Bano T, et al. Heparin and insulin in the management of hypertriglyceridemia-associated pancreatitis: case series and literature review. Arch Endocrinol Metab. 2017;61(2):198–201. doi: 10.1590/2359-3997000000244.
   PubMed Web of Science ®Google Scholar
• Marić N, Mačković M, Bakula M, et al. Hypertriglyceridemia-induced pancreatitis treated with continuous insulin infusion-Case series. Clin Endocrinol (Oxf). 2022;96(2):139–143. doi: 10.1111/cen.14554.
   PubMed Web of Science ®Google Scholar
• Pulipati VP, Amblee A, Yap SET, et al. Hypertriglyceridemia-associated acute pancreatitis: response to continuous insulin infusion. PLoS ONE. 2021;16(11):e0260495. doi: 10.1371/journal.pone.0260495.
   PubMed Web of Science ®Google Scholar
• Bruce JIE, Sánchez-Alvarez R, Sans MD, et al. Insulin protects acinar cells during pancreatitis by preserving glycolytic ATP supply to calcium pumps. Nat Commun. 2021;12(1):4386. doi: 10.1038/s41467-021-24506-w.
   PubMed Web of Science ®Google Scholar
• Näsström B, Olivecrona G, Olivecrona T, et al. Lipoprotein lipase during continuous heparin infusion: tissue stores become partially depleted. J Lab Clin Med. 2001;138(3):206–213. doi: 10.1067/mlc.2001.117666.
   PubMed Web of Science ®Google Scholar
• Litov L, Petkov P, Rangelov M, et al. Molecular mechanism of the anti-inflammatory action of heparin. IJMS. 2021;22(19):10730. doi: 10.3390/ijms221910730.
   Google Scholar
• Patil B, Meena LN, Sharma DC, et al. Impact of low-molecular-weight heparin in the treatment of moderately severe and severe acute pancreatitis; a randomized, single blind, phase 3 control trial. Int J Surg. 2022;101:106621. doi: 10.1016/j.ijsu.2022.106621.
   PubMed Web of Science ®Google Scholar
• He K, Zhang Y, Song K, et al. Randomized controlled trials of low molecular weight heparin in non-mild acute pancreatitis: a systemic review and meta-analysis. Thromb Res. 2023;221:26–29. doi: 10.1016/j.thromres.2022.11.012.
   PubMed Web of Science ®Google Scholar
• Laufs U, Parhofer KG, Ginsberg HN, et al. Clinical review on triglycerides. Eur Heart J. 2020;41(1):99–109c. doi: 10.1093/eurheartj/ehz785.
   PubMed Web of Science ®Google Scholar
• Watts GF, Cameron J, Henderson A, et al. Lipoprotein lipase deficiency due to long-term heparinization presenting as severe hypertriglyceridaemia in pregnancy. Postgrad Med J. 1991;67(794):1062–1064. doi: 10.1136/pgmj.67.794.1062.
   PubMed Web of Science ®Google Scholar
• Jin M, Peng JM, Zhu HD, et al. Continuous intravenous infusion of insulin and heparin vs plasma exchange in hypertriglyceridemia-induced acute pancreatitis. J Digest Dis. 2018;19(12):766–772. doi: 10.1111/1751-2980.12659.
   PubMed Web of Science ®Google Scholar
• Anbessie ZM, Gebremeskel YB. Hypertriglyceridemic pancreatitis managed with heparin and insulin: a case report. J Med Case Reports. 2023;17(1):256. doi: 10.1186/s13256-023-03995-x.
   PubMedGoogle Scholar
• Mederos MA, Reber HA, Girgis MD. Acute pancreatitis: a review. JAMA. 2021;325(4):382–390. doi: 10.1001/jama.2020.20317.
   PubMed Web of Science ®Google Scholar